Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CDX-585 by Celldex Therapeutics for Solid Tumor: Likelihood of Approval
CDX-585 is under clinical development by Celldex Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...